﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Renal Injury Prevention</JournalTitle>
      <Issn>2345-2781</Issn>
      <Volume>8</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2019</Year>
        <Month>06</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Comparison of icodextrin and glucose solutions for long-dwell exchange in continuous ambulatory peritoneal dialysis patients; a preliminary study</ArticleTitle>
    <FirstPage>65</FirstPage>
    <LastPage>70</LastPage>
    <ELocationID EIdType="doi">10.15171/jrip.2019.13</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Yaghoubi</LastName>
      </Author>
      <Author>
        <FirstName>Sudabeh</FirstName>
        <LastName>Alatab</LastName>
      </Author>
      <Author>
        <FirstName>Iraj</FirstName>
        <LastName>Najafi</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/jrip.2019.13</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>03</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>10</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Icodextrin is widely used in peritoneal dialysis (PD) and several clinical observations suggest the superiority of icodextrin compared with 4.25% dextrose in optimizing peritoneal ultrafiltration (UF). However this solution has been introduced to our PD centers over the last two years. Objectives: In this study we aimed to evaluate the effects of employment of this solution in our PD patients. Patients and Methods: The study was carried out in two Iranian PD centers (Shafa and Shariati centers). We included 29 established patients (12 male and 17 female, mean age 58.9 ±11.1 years) who used icodextrin for the long-dwell exchange for last 6 months. Clinical data were collected at baseline and 6 months after icodextrin administration. Results: When the data between baseline and after 6 months of icodextrin administration was evaluated, we found no significant change in evaluated parameters including 24 hours UF, 24 hours urine volume, membrane transport type, Kt/V and creatinine clearance was observed. Conclusion: Icodextrin for the long-dwell exchange did not improve the creatinine clearance despite producing, a non-significant increase in 24-hour UF, after 6 months. Due to low proportion of patients and high inter-patients variability we cannot reach a robust conclusion. Studies with bigger sample size involving several PD centers are necessary to further address this subject.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Peritoneal dialysis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ultrafiltration failure</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Peritoneal equilibrium test</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Icodextrin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Creatinin clearance</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ultrafiltration</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>